Rankings
▼
Calendar
NVCR
NovoCure Limited
$1B
Q3 2017 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$50M
+131.2% YoY
Gross Profit
$35M
69.8% margin
Operating Income
-$6M
-11.8% margin
Net Income
-$11M
-22.9% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
+30.6%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$795,000
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$262M
Total Liabilities
$146M
Stockholders' Equity
$117M
Cash & Equivalents
$82M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$50M
$22M
+131.2%
Gross Profit
$35M
$11M
+231.1%
Operating Income
-$6M
-$28M
+79.1%
Net Income
-$11M
-$34M
+65.8%
Geographic Segments
UNITED STATES
$35M
70%
E M E A
$15M
29%
JAPAN
$52,000
0%
← FY 2017
All Quarters
Q4 2017 →
NVCR Q3 2017 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena